Italia markets closed

TEVA Jul 2024 15.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,4500-0,3300 (-18,54%)
In data: 12:33PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,7800
Aperto1,4500
Denaro1,1800
Domanda1,3800
Prezzo d'esercizio15,00
Scadenza2024-07-05
Min-Max giorno1,4500 - 1,4500
Contratto - Min-MaxN/D
Volume75
Open Interest1
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.